Saturday, August 29th 

Session 1. RLS basic science session (chair: A. Salminen, Germany)

7:00 – 7:15  An Update on the Genetics of RLS (B. Schormair, Germany)

7:15 – 7:30     An update on molecular studies of RLS (F. Akcimen,  Canada) 

7:30 – 7:45     Probing the relationship between BTBD9 and MEIS1 in animal models of RLS (Y. Li, USA)

7:45 – 8:00     Sleep-related muscle activity is augmented by administration of serum from RLS patients in Btbd9 mutant mice. 
    (S. Chikahisa, Japan)

8:00 - 8:15      PTPRD: Drugging a novel RLS target (G.Uhl, USA)

Session 2. New developments in iron measurement and treatment in RLS (chair: R. Allen, USA)

8:51  – 8:30 Iron regulation, iron status and relevance to iron treatment (C. J. Earley, USA)  

8:30 – 8:45     The clinical implementation of the quantitative transcranial sonography (Celia Garcia Malo, Spain)

8:45  – 9:00    Intravenous Iron protocol for adolescents (D. Picchietti, USA)

9:15 – 9:30     Intravenous Ferric Carboxymaltose in children, a single center experience (L. DelRosso, USA)

Session 3. Young investigators (chair: R. Zak / A.S. Walters , USA)

9:30 – 10:45 up to 5 presentations 

 Sunday, August 30th 

Session 4. RLS and PLMS: clinical aspects and treatment (chair: D. Sharon, USA)

7:00 – 7:30 PLMS update (R. Allen, USA)

7:30 – 7:45 Dopaminergic treatment modulates functional brain connectivity in RLS (A. Stefani, Austria)

7:45 – 8:00 Update on Painful Willis-Ekbom disease: an unbearable and distinct form of restless legs? (E. Karroum, USA)   

8:00 – 8:15 Nearly 25% of RLS Patients Nationally Treated With Dopamine Agonists Are Taking Higher Doses Than The Maximum       Recommended By FDA And Expert Guidelines. (J. Winkelman, USA)

8:15 – 8:30 Testing the adenosine hypothesis:  a double-blind, cross-over, placebo-controlled trial with
dipyridamole  (D. Garcia-Borreguero, Spain)

8:30 – 8:45 Epidural electric spinal stimulation in a severe case of RLS/PLM  (M. Manconi, Switzerland)

Session 5. Cooperative and IRLSSG endorsed projects (chair: J. Winkelman, USA)

8:45 – 9:05  Introduction to EURLSSG and Highlights from the EURLSSG meeting (R. Silvestri, Italy)

9:05 – 9:15 RLS projects by RLS foundation (K. Dzienkowski, USA) 

9:15 – 9:25 Experimental Readouts of Animal Models of Restless Legs Syndrome: Consensus Guidelines (A. Salminen, Germany)

9:25 – 9:35 Diagnostic accuracy of RLS tools (R. Allen, USA)  

9:35 – 9:45 Opioid registry update (J. Winkelman, USA)

9:45 – 9:55 RSD project (L. DelRosso, USA)

9:55 – 10:05  Pediatric Task force (Art Walters, USA)

10:05 – 10:15 Update on AASM TF on Guidelines for treating RLS (A. Walters, USA)

10:15 – 10:25 A Call to Arms--breaking down silos and increasing interagency cooperation (R. Zak, USA)

10:25 – 10:35 Year in review  and future projects discussion (J Winkelman, USA)

10:35-10:45 Business meeting